New Diabetes Drug Gets FDA OK Under 'Abbreviated' Pathway

MONDAY, Dec. 11, 2017 — Admelog (insulin lispro), a short-acting form of insulin, has been approved by the U.S. Food and Drug Administration to treat people with either type of diabetes, for patients aged three years and older.
It’s the first drug…
Source: Topamax